Taking advantage of the radiopharmaceutical revolution “We’re on the cusp of something really exciting,” says Jilly Croasdale, head of radiopharmacy at Sandwell and West Birmingham NHS Trust.  Over the past five years, there has been a surge in new…

*Taking advantage of the radiopharmaceutical revolution*

In our latest feature, #RachelBrazil looks into why experts are questioning whether the UK has the resources to ride the #radiopharmaceutical wave

#cancer #cancertreatment #oncology #radiopharmacy

Designed by AI: the future of antibody drugs Artificial intelligence (AI) is set to transform the way antibody drugs are designed — and not just by improving or refining existing processes, but designing antibodies from the ground up.  The hope…

Our latest feature from #RachelBrazil looks at #AI and its influence on the development of antibody drugs. Meet the start-ups that are designing these treatments from scratch

#AI #AIpharma

Designed by AI: the future of antibody drugs Artificial intelligence (AI) is set to transform the way antibody drugs are designed — and not just by improving or refining existing processes, but designing antibodies from the ground up.  The hope…

*Designed by AI: the future of antibody drugs*

This week, #RachelBrazil investigates the technology companies that are using AI to create the next generation of antibody drugs

#AI #artificialintelligence #antibodydrugs #pharmacuticaltechnology #drugdiscovery

How AI is transforming drug discovery “We want to industrialise drug discovery,” says Imran Haque, senior vice president of AI and digital sciences at Recursion, a start-up founded in Salt Lake City, Utah, in 2013. The company’s vision…

*How AI is transforming drug discovery*

Here, #RachelBrazil looks at how pharmaceutical companies and start-ups are harnessing #AI to improve speed and reduce costs in the #drugdiscovery and development process

How AI is transforming drug discovery “We want to industrialise drug discovery,” says Imran Haque, senior vice president of AI and digital sciences at Recursion, a start-up founded in Salt Lake City, Utah, in 2013. The company’s vision…

This feature by #RachelBrazil looks into how pharmaceutical companies and start-ups are harnessing AI to improve speed and reduce costs at every stage of the drug discovery and development process

#AI #drugdiscovery #drugdevelopment

Engineering precision: developing the next generation of antibody drug conjugates When results from the ‘EV-302’ bladder cancer trial were presented at the European Society for Medical Oncology annual meeting in October 2023, they received a standing ovation. The study compared…

In this week's feature, #RachelBrazil examines a new generation of antibody drug conjugates that have been found to improve efficacy and minimise off-target adverse effects of cancer therapies

#Enhertu #enfortumabvedotin #antibodydrugconjugate

Microsampling: a patient-centred approach to therapeutic drug monitoring Having a blood sample taken, usually by a phlebotomist in a clinic, is an often unpleasant but necessary step in monitoring medical conditions and some medicines. However, Neil Spooner, bioanalyst…

"Microsampling could be a gateway to improved longer-term patient health"

Here, #RachelBrazil speaks to experts about #microsampling techniques, which could mean faster, less stressful blood tests for vulnerable patients, but they do come at a high cost

Engineering precision: developing the next generation of antibody drug conjugates When results from the ‘EV-302’ bladder cancer trial were presented at the European Society for Medical Oncology annual meeting in October 2023, they received a standing ovation. The study compared…

#RachelBrazil examines progress by researchers to create a new generation of antibody drug conjugates to improve efficacy and minimise off-target adverse effects of these cancer therapies
#Enhertu #enfortumabvedotin #antibodydrugconjugate